Lamichhane et al. found that the combination of PD-1 blocking and IL-10 (R) neutralization activated more T and B cells, decreasing MDSCs in the ascites of ID8 tumor-bearing mice, leading to tumor burden alleviation and survival prolongation [114]. This evidence concerns the gene IL10 and neoplasm.